[Metastatic risk factors in pheochromocytoma/paraganglioma]
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Metastatic potential defines pheochromocytoma/paraganglioma (PPGL) classification. This review details clinical, morphological, and genetic risk factors and compares diagnostic scales for metastatic PPGLs.
Area Of Science
- Endocrinology
- Oncology
- Pathology
Background
- All pheochromocytoma/paragangliomas (PPGLs) possess metastatic potential, leading to classification as metastatic or non-metastatic.
- Metastatic PPGLs can manifest synchronously or metachronously, with an overall prevalence of 15-20%.
- Risk factors encompass clinical, morphological, and genetic characteristics, including tumor size, invasion, and specific genetic mutations.
Purpose Of The Study
- To review and discuss established risk factors for metastatic PPGLs.
- To compare the sensitivity and specificity of various predictive scales for assessing metastatic PPGL risk.
Main Methods
- Literature review of clinical, morphological, and genetic risk factors for metastatic PPGLs.
- Analysis and comparison of existing predictive scales: PASS, GAPP, M-GAPP, ASES, and COPPS.
Main Results
- Identified key risk factors include age, tumor localization, hormonal secretion, size, invasion, necrosis, and genetic mutations in pseudohypoxia, kinase, and Wnt signaling pathways.
- Evaluated the diagnostic performance of various scales, highlighting differences in sensitivity and specificity.
Conclusions
- Accurate assessment of metastatic potential in PPGLs is crucial for patient management.
- Understanding risk factors and utilizing validated predictive scales can improve diagnostic accuracy and treatment strategies for metastatic PPGLs.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumors may result in a case where two people have the same mutations in an oncogene or tumor...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...